The HLA system: Immunobiology, HLA typing, antibody screening and crossmatching techniques

Journal of Clinical Pathology

Volumn 63, Issue 5, 2010, Pages 387-390

  Howell, W M ^a   Carter, V ^a   Clark, B ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; OLIGONUCLEOTIDE;

ANTIBODY SCREENING; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOBIOLOGY; NUCLEOTIDE SEQUENCE; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; SOLID PHASE SYNTHESIS;

HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; TRANSPLANTATION IMMUNOLOGY;

EID: 77951654572     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.072371     Document Type: Review

References (25)

1. Long EO, Jacobson S. Pathways of viral antigen processing and presentation to CTL defined by the mode of virus entry. Immunol Today 1989;10:45-48 (Pubitemid 19041700)
2. Stern LJ, Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins, Structure 1994;2:245-251 (Pubitemid 124001621)
3. Norman PJ, Parham P. Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors. Semin Hematol 2005;42:65-75. (Pubitemid 40544296)
4. Petersdorf EW, Malkki M. Genetics of risk factors for graft-versus-host disease. Semin Hematol 2006;43:11-23. (Pubitemid 43063331)
5. Hornick P. Direct and indirect allorecognition. Methods Mol Biol 2006;333:145-156
6. Herrera OB, Golshayan D, Tibbott R, et al. A novel pathway of alloantigen presentation by dendritic cells. J Immunol 2004;173:4828-4837 (Pubitemid 39387763)
7. Gloor J, Cosio F, Lager DJ, et al. The spectrum of antibody-mediated renal allograft injury: implications for treatment. Am J Transplant 2008;7:1367-1373 (Pubitemid 351989489)
8. Higgins R, Hathaway M, Lowe D, et al. New choices for patients needing kidney transplantation across antibody barriers. J Ren Care 2008;34:85-93.
9. Mao Q, Terasaki PI, Cai J, et al. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 2006;7:864-871 (Pubitemid 46481194)
10. Mittal KK, Mickey MR, Singal DP, et al. Serotyping for homotransplantation: refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968;6:913-927
11. Elsner HA, Blasczyk R. Immunogenetics of HLA null alleles: implications for blood stem cell transplantation. Tissue Antigens 2004;64:687-695 (Pubitemid 39628050)
12. Bunce M, O'Neill CM, Barnardo MCNM, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP0. Tissue Antigens 1995;46:355-67.
13. Krausa P, Browning M. Detection of HLA gene polymorphism. In: Browning M, McMichael A, eds. HLA and MHC: genes, molecules and function. Oxford: BIOS Scientific Publishers Ltd, 1996:113-137
14. Itoh Y, Mizuki N, Shimada T, et al. High throughput DNA typing of HLA-A, -B, -C and DRB1 by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005;57:717-729
15. Abbott WGH, Tukuitonga CF, Ofanoa M, et al. Low-cost, simultaneous, single-sequence genotyping of the HLA-A, HLA-B and HLA-C loci. Tissue Antigens 2006;68:28-37. (Pubitemid 43892873)
16. Arguello JR, Little A-M, Pay AL, et al. Mutation detection and typing of polymorphic loci through double-strand conformation analysis. Nat Genet 1998;18;192-194
17. Feucht HE, Mihatsch MJ. Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens 2005;14:592-598
18. Zachary AA, Klingman L, Thorne N, et al. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation 1995;60;498-503.
19. Harmer AW, Heads AJ, Vaughan RW. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients. Transplantation 1997;63:1828-1832
20. Kao KJ, Scornik JC, Small SJ. Enzyme-linked immunoassay for anti-HLA antibodies e an alternative to panel studies by lymphocytotoxicity. Transplantation 1993;55:192-196
21. Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microsheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006;21:2625-2629 (Pubitemid 44644542)
22. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969;280:735-739
23. Garovoy MR, Rheinschmidt MA, Bigos M, et al. Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant Proc 1983;15:1939-1944 (Pubitemid 14233896)
24. Scornik JC. Detection of alloantibodies by flow cytometry: relevance to clinical transplantation. Cytometry 1995;22:259-263
25. Billen EV, Voorter CE, Christiaans MH, et al. Luminex donor-specific crossmatches. Tissue Antigens 2008;71:507-513